Join the Diabetes, Type 2 group to help and get support from people like you.
Diabetes, Type 2 News (Page 19)
Related terms: Noninsulin-dependent Diabetes, Type 2 Diabetes, Diabetes, Type 2
FDA Expands Approval of Omnipod 5 Insulin Delivery System to Include Patients With Type 2 Diabetes
TUESDAY, Aug. 27, 2024 – On Monday, the U.S. Food and Drug Administration approved the Insulet Omnipod 5 insulin delivery system for patients with type 2 diabetes. It is the first such system for...
Diabetes Can Age Your Brain, But Lifestyle Change Can Reverse That
WEDNESDAY, Aug. 28, 2024 – Diabetes can age the brain by up to four years, a new study based on MRI scans shows. There was one silver lining: Healthy lifestyle changes could help prevent that...
After Weighting, 3.6 Million Likely to Be Newly Eligible for Semaglutide
MONDAY, Aug. 26, 2024 – Increases in eligibility for semaglutide are discussed in a research letter published online Aug. 27 in the Annals of Internal Medicine. After the Semaglutide Effects on...
FDA Clears First Automated Device to Deliver Insulin to People With Type 2 Diabetes
TUESDAY, Aug. 27, 2024 – The U.S. Food and Drug Administration on Monday approved the expanded use of an automated insulin pump system to include those with type 2 diabetes. It's the first such...
Meat Consumption Linked to Increased Incidence of Type 2 Diabetes
TUESDAY, Aug. 27, 2024 – Consumption of unprocessed red meat, processed meat, and poultry is associated with an increased incidence of type 2 diabetes, according to a study published online in the...
Type 2 Diabetes Prevalence Rose in the United States From 2012 to 2022
FRIDAY, Aug. 23, 2024 – The prevalence of diabetes increased in the United States from 2012 to 2022, according to a research letter published online July 18 in Diabetes, Obesity and Metabolism. ...
FDA Approves Zituvimet XR (sitagliptin and metformin hydrochloride) Extended-Release Tablets for Adults with Type 2 Diabetes
Ahmedabad, India, 19 July 2024 Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred to as “Zydus”) has received final approval for its New Drug Application (NDA) fro...
FDA Approves Zituvimet (sitagliptin and metformin hydrochloride) to Treat Adult Patients With Type 2 Diabetes Mellitus
November 06, 2023, Ahmedabad, India -- Zydus Lifesciences Limited (including its subsidiaries/affiliates, hereafter referred to as "Zydus") today announced that the U.S. Food and Drug Administration ...
FDA Medwatch Alert: FDA Warns Consumers of Hidden Drug Ingredients in Dr. Ergin’s SugarMD Advanced Glucose Support
November 3, 2023 -- Consumers should not purchase or use Dr. Ergin’s SugarMD Advanced Glucose Support, a product promoted and sold for blood glucose management. It may have been purchased at ww...
FDA Approves Zituvio (sitagliptin) for the Treatment of Adult Patients with Type 2 Diabetes Mellitus
AHMEDABAD, India, Oct. 20, 2023 /PRNewswire/ – Zydus Lifesciences Limited (including its subsidiaries/affiliates, hereafter referred to as 'Zydus') today announced that the U.S. Food and Drug...
FDA Approves New Class of Medicines to Treat Pediatric Type 2 Diabetes
June 20, 2023 – Today, the U.S. Food and Drug Administration approved Jardiance (empagliflozin) and Synjardy (empagliflozin and metformin hydrochloride) as additions to diet and exercise to improve...
FDA Approves Jardiance (empagliflozin) for the Treatment of Type 2 Diabetes in Children 10 Years and Older
RIDGEFIELD, Conn. and INDIANAPOLIS, June 21, 2023 /PRNewswire/ – The U.S. Food and Drug Administration (FDA) has approved Jardiance (empagliflozin) 10 mg and 25 mg tablets to lower blood sugar along...
FDA Medwatch Alert: FDA Issues Warning About Compounded Medications Containing Semaglutide Marketed for Type 2 Diabetes or Weight Loss
On May 30, 2023, the FDA posted information about medications containing semaglutide marketed for type 2 diabetes or weight loss. There are currently three FDA-approved semaglutide products which are...
FDA Approves Brenzavvy (bexagliflozin) for the Treatment of Adults with Type 2 Diabetes
MARLBOROUGH, Mass.--(BUSINESS WIRE) January 23, 2023 --TheracosBio today announced that the U.S. Food and Drug Administration (FDA) has approved Brenzavvy (bexagliflozin), an oral sodium-glucose...
Novo Nordisk Announces FDA Approval of Label Update for Rybelsus (semaglutide) Allowing Use as a First-Line Option for Adults with Type 2 Diabetes
People living with type 2 diabetes can now take Rybelsus®, the first and only oral glucagon-like peptide-1 (GLP-1) analog, along with diet and exercise, as initial therapy to help lower their A1C1,2 ...
Further information
Related condition support groups
Related drug support groups
metformin, Ozempic, Mounjaro, Victoza, Lantus, semaglutide, Trulicity, glipizide, Rybelsus, view more... tirzepatide, Jardiance, liraglutide, Lantus Solostar, Humalog, Farxiga, Novolog, Janumet, insulin glargine, Januvia, Bydureon, insulin lispro, Tresiba, dulaglutide, Levemir, insulin degludec, Invokana, glimepiride, Glucophage, Humulin N